Global Felodipine Tablets Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 95
Published Date: 08 Jan 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
According to our (Global Info Research) latest study, the global Felodipine Tablets market size was valued at US$ 266 million in 2024 and is forecast to a readjusted size of USD 358 million by 2031 with a CAGR of 4.4% during review period.
Felodipine is a calcium channel blocker. It works by affecting the movement of calcium into the cells of the heart and blood vessels. Felodipine relaxes blood vessels and increases the supply of blood and oxygen to the heart, which reduces the workload.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Felodipine Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Felodipine Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Felodipine Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Felodipine Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Felodipine Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Felodipine Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Felodipine Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astrazeneca, Sandoz, SHANXI KANGBO BIOLOGICAL PRODUCT, Changzhou Siyao Pharmaceutical, Lianhuan Pharma, Sihuan Pharma, CR Double Crane, Xiehe Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Felodipine Tablets market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ordinary Tablet
Sustained Release Tablet
Market segment by Application
Treat High Blood Pressure
Relieve Angina
Others
Major players covered
Astrazeneca
Sandoz
SHANXI KANGBO BIOLOGICAL PRODUCT
Changzhou Siyao Pharmaceutical
Lianhuan Pharma
Sihuan Pharma
CR Double Crane
Xiehe Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Felodipine Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Felodipine Tablets, with price, sales quantity, revenue, and global market share of Felodipine Tablets from 2020 to 2025.
Chapter 3, the Felodipine Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Felodipine Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Felodipine Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Felodipine Tablets.
Chapter 14 and 15, to describe Felodipine Tablets sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Felodipine Tablets Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Ordinary Tablet
1.3.3 Sustained Release Tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Felodipine Tablets Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Treat High Blood Pressure
1.4.3 Relieve Angina
1.4.4 Others
1.5 Global Felodipine Tablets Market Size & Forecast
1.5.1 Global Felodipine Tablets Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Felodipine Tablets Sales Quantity (2020-2031)
1.5.3 Global Felodipine Tablets Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca Felodipine Tablets Product and Services
2.1.4 Astrazeneca Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Astrazeneca Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Felodipine Tablets Product and Services
2.2.4 Sandoz Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Sandoz Recent Developments/Updates
2.3 SHANXI KANGBO BIOLOGICAL PRODUCT
2.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Details
2.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
2.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product and Services
2.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
2.4 Changzhou Siyao Pharmaceutical
2.4.1 Changzhou Siyao Pharmaceutical Details
2.4.2 Changzhou Siyao Pharmaceutical Major Business
2.4.3 Changzhou Siyao Pharmaceutical Felodipine Tablets Product and Services
2.4.4 Changzhou Siyao Pharmaceutical Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
2.5 Lianhuan Pharma
2.5.1 Lianhuan Pharma Details
2.5.2 Lianhuan Pharma Major Business
2.5.3 Lianhuan Pharma Felodipine Tablets Product and Services
2.5.4 Lianhuan Pharma Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Lianhuan Pharma Recent Developments/Updates
2.6 Sihuan Pharma
2.6.1 Sihuan Pharma Details
2.6.2 Sihuan Pharma Major Business
2.6.3 Sihuan Pharma Felodipine Tablets Product and Services
2.6.4 Sihuan Pharma Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sihuan Pharma Recent Developments/Updates
2.7 CR Double Crane
2.7.1 CR Double Crane Details
2.7.2 CR Double Crane Major Business
2.7.3 CR Double Crane Felodipine Tablets Product and Services
2.7.4 CR Double Crane Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 CR Double Crane Recent Developments/Updates
2.8 Xiehe Pharma
2.8.1 Xiehe Pharma Details
2.8.2 Xiehe Pharma Major Business
2.8.3 Xiehe Pharma Felodipine Tablets Product and Services
2.8.4 Xiehe Pharma Felodipine Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Xiehe Pharma Recent Developments/Updates
3 Competitive Environment: Felodipine Tablets by Manufacturer
3.1 Global Felodipine Tablets Sales Quantity by Manufacturer (2020-2025)
3.2 Global Felodipine Tablets Revenue by Manufacturer (2020-2025)
3.3 Global Felodipine Tablets Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Felodipine Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Felodipine Tablets Manufacturer Market Share in 2024
3.4.3 Top 6 Felodipine Tablets Manufacturer Market Share in 2024
3.5 Felodipine Tablets Market: Overall Company Footprint Analysis
3.5.1 Felodipine Tablets Market: Region Footprint
3.5.2 Felodipine Tablets Market: Company Product Type Footprint
3.5.3 Felodipine Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Felodipine Tablets Market Size by Region
4.1.1 Global Felodipine Tablets Sales Quantity by Region (2020-2031)
4.1.2 Global Felodipine Tablets Consumption Value by Region (2020-2031)
4.1.3 Global Felodipine Tablets Average Price by Region (2020-2031)
4.2 North America Felodipine Tablets Consumption Value (2020-2031)
4.3 Europe Felodipine Tablets Consumption Value (2020-2031)
4.4 Asia-Pacific Felodipine Tablets Consumption Value (2020-2031)
4.5 South America Felodipine Tablets Consumption Value (2020-2031)
4.6 Middle East & Africa Felodipine Tablets Consumption Value (2020-2031)
5 Market Segment by Type
5.1 Global Felodipine Tablets Sales Quantity by Type (2020-2031)
5.2 Global Felodipine Tablets Consumption Value by Type (2020-2031)
5.3 Global Felodipine Tablets Average Price by Type (2020-2031)
6 Market Segment by Application
6.1 Global Felodipine Tablets Sales Quantity by Application (2020-2031)
6.2 Global Felodipine Tablets Consumption Value by Application (2020-2031)
6.3 Global Felodipine Tablets Average Price by Application (2020-2031)
7 North America
7.1 North America Felodipine Tablets Sales Quantity by Type (2020-2031)
7.2 North America Felodipine Tablets Sales Quantity by Application (2020-2031)
7.3 North America Felodipine Tablets Market Size by Country
7.3.1 North America Felodipine Tablets Sales Quantity by Country (2020-2031)
7.3.2 North America Felodipine Tablets Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
8.1 Europe Felodipine Tablets Sales Quantity by Type (2020-2031)
8.2 Europe Felodipine Tablets Sales Quantity by Application (2020-2031)
8.3 Europe Felodipine Tablets Market Size by Country
8.3.1 Europe Felodipine Tablets Sales Quantity by Country (2020-2031)
8.3.2 Europe Felodipine Tablets Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Felodipine Tablets Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Felodipine Tablets Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Felodipine Tablets Market Size by Region
9.3.1 Asia-Pacific Felodipine Tablets Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Felodipine Tablets Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
10.1 South America Felodipine Tablets Sales Quantity by Type (2020-2031)
10.2 South America Felodipine Tablets Sales Quantity by Application (2020-2031)
10.3 South America Felodipine Tablets Market Size by Country
10.3.1 South America Felodipine Tablets Sales Quantity by Country (2020-2031)
10.3.2 South America Felodipine Tablets Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Felodipine Tablets Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Felodipine Tablets Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Felodipine Tablets Market Size by Country
11.3.1 Middle East & Africa Felodipine Tablets Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Felodipine Tablets Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
12.1 Felodipine Tablets Market Drivers
12.2 Felodipine Tablets Market Restraints
12.3 Felodipine Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Felodipine Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Felodipine Tablets
13.3 Felodipine Tablets Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Felodipine Tablets Typical Distributors
14.3 Felodipine Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Felodipine Tablets Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Felodipine Tablets Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 4. Astrazeneca Major Business
Table 5. Astrazeneca Felodipine Tablets Product and Services
Table 6. Astrazeneca Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Astrazeneca Recent Developments/Updates
Table 8. Sandoz Basic Information, Manufacturing Base and Competitors
Table 9. Sandoz Major Business
Table 10. Sandoz Felodipine Tablets Product and Services
Table 11. Sandoz Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Sandoz Recent Developments/Updates
Table 13. SHANXI KANGBO BIOLOGICAL PRODUCT Basic Information, Manufacturing Base and Competitors
Table 14. SHANXI KANGBO BIOLOGICAL PRODUCT Major Business
Table 15. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Product and Services
Table 16. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
Table 18. Changzhou Siyao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Changzhou Siyao Pharmaceutical Major Business
Table 20. Changzhou Siyao Pharmaceutical Felodipine Tablets Product and Services
Table 21. Changzhou Siyao Pharmaceutical Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Changzhou Siyao Pharmaceutical Recent Developments/Updates
Table 23. Lianhuan Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Lianhuan Pharma Major Business
Table 25. Lianhuan Pharma Felodipine Tablets Product and Services
Table 26. Lianhuan Pharma Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Lianhuan Pharma Recent Developments/Updates
Table 28. Sihuan Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Sihuan Pharma Major Business
Table 30. Sihuan Pharma Felodipine Tablets Product and Services
Table 31. Sihuan Pharma Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Sihuan Pharma Recent Developments/Updates
Table 33. CR Double Crane Basic Information, Manufacturing Base and Competitors
Table 34. CR Double Crane Major Business
Table 35. CR Double Crane Felodipine Tablets Product and Services
Table 36. CR Double Crane Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. CR Double Crane Recent Developments/Updates
Table 38. Xiehe Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Xiehe Pharma Major Business
Table 40. Xiehe Pharma Felodipine Tablets Product and Services
Table 41. Xiehe Pharma Felodipine Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Xiehe Pharma Recent Developments/Updates
Table 43. Global Felodipine Tablets Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 44. Global Felodipine Tablets Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. Global Felodipine Tablets Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 46. Market Position of Manufacturers in Felodipine Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 47. Head Office and Felodipine Tablets Production Site of Key Manufacturer
Table 48. Felodipine Tablets Market: Company Product Type Footprint
Table 49. Felodipine Tablets Market: Company Product Application Footprint
Table 50. Felodipine Tablets New Market Entrants and Barriers to Market Entry
Table 51. Felodipine Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Felodipine Tablets Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. Global Felodipine Tablets Sales Quantity by Region (2020-2025) & (K Units)
Table 54. Global Felodipine Tablets Sales Quantity by Region (2026-2031) & (K Units)
Table 55. Global Felodipine Tablets Consumption Value by Region (2020-2025) & (USD Million)
Table 56. Global Felodipine Tablets Consumption Value by Region (2026-2031) & (USD Million)
Table 57. Global Felodipine Tablets Average Price by Region (2020-2025) & (US$/Unit)
Table 58. Global Felodipine Tablets Average Price by Region (2026-2031) & (US$/Unit)
Table 59. Global Felodipine Tablets Sales Quantity by Type (2020-2025) & (K Units)
Table 60. Global Felodipine Tablets Sales Quantity by Type (2026-2031) & (K Units)
Table 61. Global Felodipine Tablets Consumption Value by Type (2020-2025) & (USD Million)
Table 62. Global Felodipine Tablets Consumption Value by Type (2026-2031) & (USD Million)
Table 63. Global Felodipine Tablets Average Price by Type (2020-2025) & (US$/Unit)
Table 64. Global Felodipine Tablets Average Price by Type (2026-2031) & (US$/Unit)
Table 65. Global Felodipine Tablets Sales Quantity by Application (2020-2025) & (K Units)
Table 66. Global Felodipine Tablets Sales Quantity by Application (2026-2031) & (K Units)
Table 67. Global Felodipine Tablets Consumption Value by Application (2020-2025) & (USD Million)
Table 68. Global Felodipine Tablets Consumption Value by Application (2026-2031) & (USD Million)
Table 69. Global Felodipine Tablets Average Price by Application (2020-2025) & (US$/Unit)
Table 70. Global Felodipine Tablets Average Price by Application (2026-2031) & (US$/Unit)
Table 71. North America Felodipine Tablets Sales Quantity by Type (2020-2025) & (K Units)
Table 72. North America Felodipine Tablets Sales Quantity by Type (2026-2031) & (K Units)
Table 73. North America Felodipine Tablets Sales Quantity by Application (2020-2025) & (K Units)
Table 74. North America Felodipine Tablets Sales Quantity by Application (2026-2031) & (K Units)
Table 75. North America Felodipine Tablets Sales Quantity by Country (2020-2025) & (K Units)
Table 76. North America Felodipine Tablets Sales Quantity by Country (2026-2031) & (K Units)
Table 77. North America Felodipine Tablets Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Felodipine Tablets Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Felodipine Tablets Sales Quantity by Type (2020-2025) & (K Units)
Table 80. Europe Felodipine Tablets Sales Quantity by Type (2026-2031) & (K Units)
Table 81. Europe Felodipine Tablets Sales Quantity by Application (2020-2025) & (K Units)
Table 82. Europe Felodipine Tablets Sales Quantity by Application (2026-2031) & (K Units)
Table 83. Europe Felodipine Tablets Sales Quantity by Country (2020-2025) & (K Units)
Table 84. Europe Felodipine Tablets Sales Quantity by Country (2026-2031) & (K Units)
Table 85. Europe Felodipine Tablets Consumption Value by Country (2020-2025) & (USD Million)
Table 86. Europe Felodipine Tablets Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-Pacific Felodipine Tablets Sales Quantity by Type (2020-2025) & (K Units)
Table 88. Asia-Pacific Felodipine Tablets Sales Quantity by Type (2026-2031) & (K Units)
Table 89. Asia-Pacific Felodipine Tablets Sales Quantity by Application (2020-2025) & (K Units)
Table 90. Asia-Pacific Felodipine Tablets Sales Quantity by Application (2026-2031) & (K Units)
Table 91. Asia-Pacific Felodipine Tablets Sales Quantity by Region (2020-2025) & (K Units)
Table 92. Asia-Pacific Felodipine Tablets Sales Quantity by Region (2026-2031) & (K Units)
Table 93. Asia-Pacific Felodipine Tablets Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-Pacific Felodipine Tablets Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South America Felodipine Tablets Sales Quantity by Type (2020-2025) & (K Units)
Table 96. South America Felodipine Tablets Sales Quantity by Type (2026-2031) & (K Units)
Table 97. South America Felodipine Tablets Sales Quantity by Application (2020-2025) & (K Units)
Table 98. South America Felodipine Tablets Sales Quantity by Application (2026-2031) & (K Units)
Table 99. South America Felodipine Tablets Sales Quantity by Country (2020-2025) & (K Units)
Table 100. South America Felodipine Tablets Sales Quantity by Country (2026-2031) & (K Units)
Table 101. South America Felodipine Tablets Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South America Felodipine Tablets Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & Africa Felodipine Tablets Sales Quantity by Type (2020-2025) & (K Units)
Table 104. Middle East & Africa Felodipine Tablets Sales Quantity by Type (2026-2031) & (K Units)
Table 105. Middle East & Africa Felodipine Tablets Sales Quantity by Application (2020-2025) & (K Units)
Table 106. Middle East & Africa Felodipine Tablets Sales Quantity by Application (2026-2031) & (K Units)
Table 107. Middle East & Africa Felodipine Tablets Sales Quantity by Country (2020-2025) & (K Units)
Table 108. Middle East & Africa Felodipine Tablets Sales Quantity by Country (2026-2031) & (K Units)
Table 109. Middle East & Africa Felodipine Tablets Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & Africa Felodipine Tablets Consumption Value by Country (2026-2031) & (USD Million)
Table 111. Felodipine Tablets Raw Material
Table 112. Key Manufacturers of Felodipine Tablets Raw Materials
Table 113. Felodipine Tablets Typical Distributors
Table 114. Felodipine Tablets Typical Customers
List of Figures
Figure 1. Felodipine Tablets Picture
Figure 2. Global Felodipine Tablets Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Felodipine Tablets Revenue Market Share by Type in 2024
Figure 4. Ordinary Tablet Examples
Figure 5. Sustained Release Tablet Examples
Figure 6. Global Felodipine Tablets Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Felodipine Tablets Revenue Market Share by Application in 2024
Figure 8. Treat High Blood Pressure Examples
Figure 9. Relieve Angina Examples
Figure 10. Others Examples
Figure 11. Global Felodipine Tablets Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Felodipine Tablets Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Felodipine Tablets Sales Quantity (2020-2031) & (K Units)
Figure 14. Global Felodipine Tablets Price (2020-2031) & (US$/Unit)
Figure 15. Global Felodipine Tablets Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Felodipine Tablets Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Felodipine Tablets by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Felodipine Tablets Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Felodipine Tablets Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Felodipine Tablets Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Felodipine Tablets Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Felodipine Tablets Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Felodipine Tablets Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Felodipine Tablets Average Price by Type (2020-2031) & (US$/Unit)
Figure 30. Global Felodipine Tablets Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Felodipine Tablets Revenue Market Share by Application (2020-2031)
Figure 32. Global Felodipine Tablets Average Price by Application (2020-2031) & (US$/Unit)
Figure 33. North America Felodipine Tablets Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Felodipine Tablets Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Felodipine Tablets Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Felodipine Tablets Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Felodipine Tablets Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Felodipine Tablets Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Felodipine Tablets Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Felodipine Tablets Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 45. France Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Felodipine Tablets Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Felodipine Tablets Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Felodipine Tablets Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Felodipine Tablets Consumption Value Market Share by Region (2020-2031)
Figure 53. China Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 56. India Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Felodipine Tablets Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Felodipine Tablets Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Felodipine Tablets Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Felodipine Tablets Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Felodipine Tablets Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Felodipine Tablets Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Felodipine Tablets Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Felodipine Tablets Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Felodipine Tablets Consumption Value (2020-2031) & (USD Million)
Figure 73. Felodipine Tablets Market Drivers
Figure 74. Felodipine Tablets Market Restraints
Figure 75. Felodipine Tablets Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Felodipine Tablets in 2024
Figure 78. Manufacturing Process Analysis of Felodipine Tablets
Figure 79. Felodipine Tablets Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Astrazeneca Sandoz SHANXI KANGBO BIOLOGICAL PRODUCT Changzhou Siyao Pharmaceutical Lianhuan Pharma Sihuan Pharma CR Double Crane Xiehe Pharma
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>